1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Assumptions for the Study
3 Executive Summary (Page No. – 26)
4 Premium Insights (Page No. – 30)
4.1 Non-Invasive Prenatal Testing Market: Overview
4.2 NIPT Consumables Market Size, By Type, 2016 vs 2021 (USD Million)
4.3 NIPT Instruments Market Size, By Type, 2016 vs 2021 (USD Million)
4.4 Geographic Analysis: Market, By Method (2016)
4.5 NIPT Market, By Application (2016–2021)
4.6 Non-Invasive Prenatal Testing Market Size, By End User, 2016 vs 2021 (USD Million)
4.7 Geographic Snapshot (2016–2021)
5 Market Overview (Page No. – 34)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 High Risk of Chromosomal Abnormalities With Increasing Maternal Age
5.1.1.2 Growing Preference for Non-Invasive Techniques Over Invasive Methods
5.1.1.3 Launch of New and Advanced Products
5.1.1.4 Improving Reimbursement Scenario for NIPT
5.1.1.5 Programs Focusing on Increasing the Awareness of NIPT
5.1.2 Restraint
5.1.2.1 Lack of Skilled Professionals
5.1.3 Opportunity
5.1.3.1 Untapped Emerging Markets
5.1.4 Challenge
5.1.4.1 Reliability of Test Results Especially in Obese Women
6 Non-Invasive Prenatal Testing Market, By Product (Page No. – 41)
6.1 Introduction
6.2 Consumables
6.2.1 Assay Kits & Reagents
6.2.2 Disposables
6.3 Instruments
6.3.1 Ultrasound Devices
6.3.2 Next-Generation Sequencing Systems
6.3.3 Polymerase Chain Reaction Instruments
6.3.4 Microarrays
6.3.5 Other Instruments
7 Non-Invasive Prenatal Testing Market, By Method (Page No. – 52)
7.1 Introduction
7.2 Ultrasound Detection
7.3 Biochemical Screening Tests
7.4 Cell-Free Dna in Maternal Plasma Tests
7.5 Fetal Cells in Maternal Blood Tests
8 Non-Invasive Prenatal Testing Market, By Application (Page No. – 62)
8.1 Introduction
8.2 Trisomy
8.3 Microdeletion Syndrome
8.4 Other Applications
9 Non-Invasive Prenatal Testing Market, By End User (Page No. – 69)
9.1 Introduction
9.2 Diagnostic Laboratories
9.3 Hospitals
10 Non-Invasive Prenatal Testing Market, By Region (Page No. – 75)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Rest of Europe (RoE)
10.4 Asia
10.5 Rest of the World (RoW)
11 Competitive Landscape (Page No. – 104)
11.1 Overview
11.2 Market Analysis
11.3 Competitive Situation and Trends
11.3.1 Partnerships, Collaborations, & Agreements
11.3.2 Product Launches
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Strategies
12 Company Profile (Page No. – 112)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Ge Healthcare (A Wholly Owned Subsidiary of General Electric Company)
12.3 Koninklijke Philips N.V.
12.4 Illumina, Inc.
12.5 Thermo Fisher Scientific, Inc.
12.6 F. Hoffman-La Roche Ltd.
12.7 Pacific Biosciences of California, Inc.
12.8 Perkinelmer, Inc.
12.9 Qiagen N.V.
12.10 Agilent Technologies, Inc.
12.11 Beijing Genomics Institute
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 141)
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
Table 1 Incidence Rate of Trisomies
Table 2 Risk of Down Syndrome With Increasing Maternal Age
Table 3 Comparison of Non-Invasive and Invasive Prenatal Testing
Table 4 NIPT Reimbursement Scenario, By Country
Table 5 Public Healthcare Expenditure (% of GDP)
Table 6 Global Non-Invasive Prenatal Testing Market Size, By Product, 2014–2021 (USD Million)
Table 7 Global NIPT Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 8 Global NIPT Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 9 North America: NIPT Consumables Market Size, By Country, 2014–2021 (USD Million)
Table 10 Europe: NIPT Consumables Market Size, By Country, 2014–2021 (USD Million)
Table 11 Global NIPT Assay Kits and Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 12 Global NIPT Disposables Market Size, By Region, 2014–2021 (USD Million)
Table 13 Global NIPT Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 14 Global NIPT Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 15 North America: NIPT Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 16 Europe: NIPT Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 17 Global NIPT Ultrasound Devices Market Size, By Region, 2014–2021 (USD Million)
Table 18 Global NIPT Next-Generation Sequencing Systems Market Size, By Region, 2014–2021 (USD Million)
Table 19 Global NIPT Pcr Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 20 Global NIPT Microarrays Market Size, By Region, 2014–2021 (USD Million)
Table 21 Other NIPT Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 22 Global Non-Invasive Prenatal Testing Market Size, By Method, 2014-2021 (USD Million)
Table 23 Global Market Size for Ultrasound Detection, By Region, 2014-2021 (USD Million)
Table 24 North America: Market Size for Ultrasound Detection, By Country, 2014-2021 (USD Million)
Table 25 Europe: NIPT Market Size for Ultrasound Detection, By Country, 2014-2021 (USD Million)
Table 26 Global Non-Invasive Prenatal Testing Market Size for Biochemical Screening Tests, By Region, 2014-2021 (USD Million)
Table 27 North America: Market Size for Biochemical Screening Tests, By Country, 2014-2021 (USD Million)
Table 28 Europe: Market Size for Biochemical Screening Tests, By Country, 2014-2021 (USD Million)
Table 29 Global Market Size for Cfdna in Maternal Plasma Tests, By Region, 2014-2021 (USD Million)
Table 30 North America: NIPT Market Size for Cfdna in Maternal Plasma Tests, By Country, 2014-2021 (USD Million)
Table 31 Europe: NIPT Market Size for Cfdna in Maternal Plasma Tests, By Country, 2014-2021 (USD Million)
Table 32 Global Non-Invasive Prenatal Testing Market Size for Fcmb Tests, By Region, 2014-2021 (USD Million)
Table 33 North America: Market Size for Fcmb Tests, By Country, 2014-2021 (USD Million)
Table 34 Europe: Market Size for Fcmb Tests, By Country, 2014-2021 (USD Million)
Table 35 NIPT Market Size, By Application, 2014-2021 (USD Million)
Table 36 Non-Invasive Prenatal Testing Market Size for Trisomy, By Region, 2014-2021 (USD Million)
Table 37 North America: Market Size for Trisomy, By Country, 2014-2021 (USD Million)
Table 38 Europe: NIPT Market Size for Trisomy, By Country, 2014-2021 (USD Million)
Table 39 NIPT Market Size for Microdeletion Syndrome, By Region, 2014-2021 (USD Million)
Table 40 North America: Non-Invasive Prenatal Testing Market Size for Microdeletion Syndrome, By Country, 2014-2021 (USD Million)
Table 41 Europe: Non-Invasive Prenatal Testing Market Size Microdeletion Syndrome, By Country, 2014-2021 (USD Million)
Table 42 Market Size for Other Applications, By Region, 2014-2021 (USD Million)
Table 43 North America: Market Size for Other Applications, By Country, 2014-2021 (USD Million)
Table 44 Europe: Market Size for Other Applications, By Country, 2014-2021 (USD Million)
Table 45 Non-Invasive Prenatal Testing Market Size, By End User, 2014–2021 (USD Million)
Table 46 NIPT Market Size for Diagnostic Laboratories, By Region, 2014–2021 (USD Million)
Table 47 North America: NIPT Market Size for Diagnostic Laboratories, By Country, 2014–2021 (USD Million)
Table 48 Europe: Non-Invasive Prenatal Testing Market Size for Diagnostic Laboratories, By Country, 2014–2021 (USD Million)
Table 49 Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 50 North America: Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 51 Europe: Non-Invasive Prenatal Testing Market Size for Hospitals, By Country, 2014–2021 (USD Million)
Table 52 NIPT Market Size, By Region, 2014-2021 (USD Million)
Table 53 North America: Non-Invasive Prenatal Testing Market Size, By Product, 2014-2021 (USD Million)
Table 54 North America: Testing Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 55 North America: NIPT Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 56 North America: Market Size, By Method, 2014-2021 (USD Million)
Table 57 North America: Market Size, By Application, 2014-2021 (USD Million)
Table 58 North America: Market Size, By End User, 2014-2021 (USD Million)
Table 59 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 60 U.S.: Non-Invasive Prenatal Testing Market Size, By Product, 2014-2021 (USD Million)
Table 61 U.S.: Market Size, By Method, 2014-2021 (USD Million)
Table 62 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 63 U.S.: NIPT Market Size, By End User, 2014-2021 (USD Million)
Table 64 Canada: Non-Invasive Prenatal Testing Market Size, By Product, 2014-2021 (USD Million)
Table 65 Canada: Testing Market Size, By Method, 2014-2021 (USD Million)
Table 66 Canada: Testing Market Size, By Application, 2014-2021 (USD Million)
Table 67 Canada: NIPT Market Size, By End User, 2014-2021 (USD Million)
Table 68 Europe: Non-Invasive Prenatal Testing Market Size, By Country, 2014-2021 (USD Million)
Table 69 Europe: Market Size, By Product, 2014-2021 (USD Million)
Table 70 Europe: Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 71 Europe: Non-Invasive Prenatal Testing Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 72 Europe: Market Size, By Method, 2014-2021 (USD Million)
Table 73 Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 74 Europe: NIPT Market Size, By End User, 2014-2021 (USD Million)
Table 75 Germany: Non-Invasive Prenatal Testing Market Size, By Product, 2014-2021 (USD Million)
Table 76 Germany: Market Size, By Method, 2014-2021 (USD Million)
Table 77 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 78 Germany: Testing Market Size, By End User, 2014-2021 (USD Million)
Table 79 France: Non-Invasive Prenatal Testing Market Size, By Product, 2014-2021 (USD Million)
Table 80 France: Market Size, By Method, 2014-2021 (USD Million)
Table 81 France: Market Size, By Application, 2014-2021 (USD Million)
Table 82 France: Market Size, By End User, 2014-2021 (USD Million)
Table 83 U.K.: Non-Invasive Prenatal Testing Market Size, By Product, 2014-2021(USD Million)
Table 84 U.K.: Market Size, By Method, 2014-2021(USD Million)
Table 85 U.K.: NIPT Market Size, By Application, 2014-2021 (USD Million)
Table 86 U.K.: Testing Market Size, By End User, 2014-2021 (USD Million)
Table 87 RoE: Market Size, By Product, 2014-2021 (USD Million)
Table 88 RoE: Market Size, By Method, 2014-2021 (USD Million)
Table 89 RoE: Market Size, By Application, 2014-2021 (USD Million)
Table 90 RoE: Non-Invasive Prenatal Testing Market Size, By End User, 2014-2021 (USD Million)
Table 91 Asia: Market Size, By Product, 2014-2021 (USD Million)
Table 92 Asia: Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 93 Asia: Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 94 Asia: Market Size, By Method, 2014-2021 (USD Million)
Table 95 Asia: Non-Invasive Prenatal Testing Market Size, By Application, 2014-2021 (USD Million)
Table 96 Asia: Market Size, By End User, 2014-2021 (USD Million)
Table 97 RoW: Market Size, By Product, 2014-2021 (USD Million)
Table 98 RoW: NIPT Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 99 RoW: Instruments Market Size, By Type, 2014-2021 (USD Million)
Table 100 RoW: Non-Invasive Prenatal Testing Market Size, By Method, 2014-2021 (USD Million)
Table 101 RoW: NIPT Market Size, By Application, 2014-2021 (USD Million)
Table 102 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 103 Market Ranking, By Key Player, 2015
Table 104 Partnerships, Collaborations, & Agreements (2014-2017)
Table 105 Product Launches (2014–2017)
Table 106 Acquisitions (2014–2017)
Table 107 Expansions (2014–2017)
Table 108 Other Strategies (2014–2017)
Table 109 Exchange Rate (Used for the Conversion of Euro to USD)
Table 110 Exchange Rate (Used for the Conversion of CHF to USD)
List of Figures (48 Figures)
Figure 1 Non-Invasive Prenatal Testing Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Key Data From Secondary Sources
Figure 8 Key Data From Primary Sources
Figure 9 Non-Invasive Prenatal Testing Market, By Method, 2016 vs 2021 (USD Million)
Figure 10 Market, By Product, 2016 vs 2021 (USD Million)
Figure 11 NIPT Market, By Application, 2016 vs 2021 (USD Million)
Figure 12 Non-Invasive Prenatal Testing Market, By End User, 2016 vs 2021 (USD Million)
Figure 13 North America Dominated the Global NIPT Market in 2016
Figure 14 High Risk of Chromosomal Abnormality Associated With Increasing Maternal Age is Driving the Market Growth for Non-Invasive Prenatal Testing
Figure 15 Assay Kits & Reagents Dominated the NIPT Consumables Market in 2016
Figure 16 NGS Systems to Register the Highest CAGR in the NIPT Instruments Market From 2016 to 2021
Figure 17 Ultrasound Detection Commanded the Largest Share of the Market in 2016
Figure 18 Trisomy Was the Largest Application Segment in the Market in 2016
Figure 19 Diagnostic Laboratories Dominated the Non-Invasive Prenatal Testing Market in 2016
Figure 20 Asia to Register the Highest Growth During the Forecast Period
Figure 21 NIPT Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Non-Invasive Prenatal Testing Market Segmentation, By Product
Figure 23 Consumables to Dominate the Market During the Forecast Period
Figure 24 Cfdna in Maternal Plasma Tests to Grow at the Highest CAGR During the Forecast Period
Figure 25 North America to Dominate the Market During Forecast Period
Figure 26 Asia to Witness Highest Growth in the Biochemical Screening Tests Market During 2016–2021
Figure 27 Asia to Witness Highest Growth During the Forecast Period
Figure 28 North America to Dominate the Fcmb Tests Market During the Forecast Period
Figure 29 Trisomy to Dominate the NIPT Market, By Application, During the Forecast Period
Figure 30 Diagnostic Laboratories Dominated the Non-Invasive Prenatal Testing End-User Market in 2016
Figure 31 North America to Dominate the Market During the Forecast Period
Figure 32 North America: Non-Invasive Prenatal Testing Market Snapshot
Figure 33 Europe: Market Snapshot
Figure 34 Asia: NIPT Market Snapshot
Figure 35 RoW: Market Snapshot
Figure 36 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2014 and 2016
Figure 37 Market Evolution Framework
Figure 38 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy Adopted By Market Players
Figure 39 Product Mix of the Top Players in the NIPT Market
Figure 40 General Electric Company: Company Snapshot (2015)
Figure 41 Koninklijke Philips N.V.: Company Snapshot (2016)
Figure 42 Illumina, Inc.: Company Snapshot (2016)
Figure 43 Thermo Fisher Scientific, Inc.: Company Snapshot (2016)
Figure 44 F. Hoffmann-La Roche Ltd: Company Snapshot (2016)
Figure 45 Pacific Biosciences of California, Inc.: Company Snapshot (2016)
Figure 46 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 47 Qiagen N.V.: Company Snapshot (2016)
Figure 48 Agilent Technologies, Inc.: Company Snapshot (2016)
【レポートのキーワード】
新型出生前診断（NIPT）、新型出生前診断装置、超音波装置、NGS、PCR、マイクロアレイ
